TY - JOUR
T1 - HIV Pre-exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend planned parenthood
AU - Calabrese, Sarah K.
AU - Dovidio, John F.
AU - Tekeste, Mehrit
AU - Taggart, Tamara
AU - Galvao, Rachel W.
AU - Safon, Cara B.
AU - Willie, Tiara C.
AU - Caldwell, Abigail
AU - Kaplan, Clair
AU - Kershaw, Trace S.
N1 - Funding Information:
The authors thank the Planned Parenthood patients who generously contributed their time and effort by participating in this study. They are grateful to Ms. Susan Lane for her help with data collection and other facets of the study. They appreciate the funding and resources provided by the Center for Interdisciplinary Research on AIDS (CIRA) Pilot Projects in HIV Program at Yale University.
Funding Information:
Supported by the Yale University Center for Interdisciplinary Research on AIDS and the National Institute of Mental Health (NIMH) via Award Number P30-MH062294. S.K.C. was supported by the NIMH via Award Number K01-MH103080. T.T. was supported by the NIMH and the National Institute on Drug Abuse (NIDA) via Award Numbers T32-MH020031 and R25-DA035692, respectively. T.C.W. was supported by the NIMH via Award Numbers F31-MH113508 and R25-MH083620. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIMH, NIDA, National Institutes of Health (NIH), or Planned Parenthood Federation of America, Inc.
Publisher Copyright:
© 2018 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Background: Pre-exposure prophylaxis (PrEP) uptake has lagged among US women. PrEP stigma is a recognized barrier to uptake among men who have sex with men but remains largely unexplored among women. This study examined the pervasiveness of PrEP stigma among US women and its implications for uptake. Setting/Methods: In a 2017 online survey of Planned Parenthood patients drawn from the 3 cities with the highest numbers of new HIV infections in Connecticut, 597 heterosexually active, HIV-negative, PrEP-inexperienced women reported background characteristics, 2 dimensions of anticipated PrEP stigma (PrEP-user stereotypes and PrEP disapproval by others), and 3 indicators of potential PrEP uptake (interest in learning more about PrEP, intention to use PrEP, and comfort discussing PrEP with a provider). Results: Participants commonly perceived PrEP-user stereotypes, with many believing that others would regard them as promiscuous (37%), HIV-positive (32%), bad (14%), or gay (11%) if they used PrEP. Thirty percent would feel ashamed to disclose PrEP use. Many participants expected disapproval by family (36%), sex partners (34%), and friends (25%). In adjusted analyses, perception of PrEP-user stereotypes was uniquely associated with less comfort discussing PrEP with a provider. Expected PrEP disapproval by others was uniquely associated with less PrEP interest, less intention to use PrEP, and less comfort discussing PrEP with a provider. Exploratory moderation analyses suggested that intention to use PrEP was greatest when participants anticipated low levels of both PrEP-user stereotypes and PrEP disapproval by others. Conclusions: Findings highlight the need for positive messaging targeting potential PrEP users and their social networks to increase PrEP acceptance and uptake.
AB - Background: Pre-exposure prophylaxis (PrEP) uptake has lagged among US women. PrEP stigma is a recognized barrier to uptake among men who have sex with men but remains largely unexplored among women. This study examined the pervasiveness of PrEP stigma among US women and its implications for uptake. Setting/Methods: In a 2017 online survey of Planned Parenthood patients drawn from the 3 cities with the highest numbers of new HIV infections in Connecticut, 597 heterosexually active, HIV-negative, PrEP-inexperienced women reported background characteristics, 2 dimensions of anticipated PrEP stigma (PrEP-user stereotypes and PrEP disapproval by others), and 3 indicators of potential PrEP uptake (interest in learning more about PrEP, intention to use PrEP, and comfort discussing PrEP with a provider). Results: Participants commonly perceived PrEP-user stereotypes, with many believing that others would regard them as promiscuous (37%), HIV-positive (32%), bad (14%), or gay (11%) if they used PrEP. Thirty percent would feel ashamed to disclose PrEP use. Many participants expected disapproval by family (36%), sex partners (34%), and friends (25%). In adjusted analyses, perception of PrEP-user stereotypes was uniquely associated with less comfort discussing PrEP with a provider. Expected PrEP disapproval by others was uniquely associated with less PrEP interest, less intention to use PrEP, and less comfort discussing PrEP with a provider. Exploratory moderation analyses suggested that intention to use PrEP was greatest when participants anticipated low levels of both PrEP-user stereotypes and PrEP disapproval by others. Conclusions: Findings highlight the need for positive messaging targeting potential PrEP users and their social networks to increase PrEP acceptance and uptake.
KW - HIV infections
KW - health care
KW - pre-exposure prophylaxis
KW - prevention of sexual transmission
KW - social stigma
KW - women
UR - http://www.scopus.com/inward/record.url?scp=85054033849&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054033849&partnerID=8YFLogxK
U2 - 10.1097/QAI.0000000000001762
DO - 10.1097/QAI.0000000000001762
M3 - Article
C2 - 29847480
AN - SCOPUS:85054033849
SN - 1525-4135
VL - 79
SP - 46
EP - 53
JO - Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
JF - Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
IS - 1
ER -